Novartis to build radioligand therapy plant in Texas
Novartis will build a 46,000-square-foot radioligand therapy site in Denton, Texas. The facility supports a broader expansion to mitigate drug import tariffs.
Xurve View
Insights:
Xurve View
The Swiss drugmaker NOVARTIS AG-2ND LINE[Symbol:{\"assets\":{\"symbol\":\"0QM7.L\"}}] announced on Wednesday its intention to construct a new radioligand therapy (RLT) manufacturing facility in Denton, Texas. This project represents the company's first such facility in Texas and its fifth across the United States[Country:{\"assets\":{\"country\":\"US\"}}].
